menu

FDA D.I.S.C.O.: L-Glutamine for Sickle Cell Disease

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

FDA D.I.S.C.O.: L-Glutamine for Sickle Cell Disease

close
FDA D.I.S.C.O.: L-Glutamine for Sickle Cell Disease
Restart
Resume
Read full article
Choose a format
Media formats available:
A pre-test is required to view this content.
A pre-survey is required to view this content.
Details
Comments
  • Overview

    FDA medical oncologists discuss the July 7, 2017, approval of l-glutamine to reduce the acute complications of sickle cell disease.

    Released August 17, 2017

Facebook Comments

Recommended
Details
Comments
  • Overview

    FDA medical oncologists discuss the July 7, 2017, approval of l-glutamine to reduce the acute complications of sickle cell disease.

    Released August 17, 2017

Facebook Comments

Programs 5/13/21